company cure back which is working on a cover 1000 back seen that stake will cost 300000000 euros karabakh is based in germany and is about to begin clinical trials for a coronavirus vaccine later this month here's a closer look at the company that's attracting both scientific and political interests. q evacuate one of the big hopes when it comes to developing a vaccine against the corona virus its method is particularly promising now the german government has taken a 20 percent stake in the company giving it a 300000000 euro boost. this investment is a way of providing back with security so that it can continue to work with commitment towards producing a vaccine. cure back hit the headlines this year when the us government allegedly attempted to entice the company over to america monday's move is therefore also about sending a clear message about the government's industrial policy. we want high tech businesses companies which serves people to continue to develop their products in germany and europe and we want to ensure such companies have the conditions they need here. is such a company.

quickly how close this curve back actually to developing a vaccine that's ready for market well karabakh says it hopes to get this vaccine out by the end of the year we don't know if that's actually going to going to happen most vaccines do fail the reason why karabakh is really getting a lot of attention is they've had pretty successful rates and animals they're just starting human trials now and they have been beat the market by a lot of other companies so we don't really know yet but it could be in the coming months shall see delaney for us thank you very much. mexico reported more than $4000.00 new coronavirus infections on sunday along with nearly $270.00 fatalities that brings its total confirmed cases to more than 146008 death toll of $17000.00 but even the government says the real number of infections is probably significantly higher with all of one 1st responder and the challenges he faces in mexico city. he's. he can hardly breathe. he had this 38 degree fever he hasn't been able to stand for 3 days we're taking him to his i don't know the tough day for the red cross in mexico.

year we don't know if that's actually going to going to happen most vaccines do fail the reason why karabakh is really getting a lot of attention is they have they've had pretty successful rates and animals they're just starting human trials now and they have been beat the market by a lot of other companies so we don't really know yet but it could be in the coming months shall see dylan for us thank you very much let's catch i found some other stories from around the world in a groundbreaking decision the us supreme court has ruled that workers cannot be fired for being gay or transgender waffly half the country was previously protected by state laws now the supreme court says that the language of the 1964 civil rights act that bars gender discrimination also applies to sexual orientation and gender identity. a russian court has sentenced former u.s. marine paul wieland to 16 years in prison after finding him guilty of espionage he was accused of having obtained classified state information the u.s. says it is outraged by williams' conviction and is calling for his immediate release. british